XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost $ 1,683,394 $ 1,641,139
Gross Unrealized Gains 61 159
Gross Unrealized Losses (9,608) (15,926)
Aggregate Fair Value 1,673,847 1,625,372
Cash and Cash Equivalents 785,414 724,531 [1]
Short-term Marketable Securities 340,431 567,006 [1]
Long-term Marketable Securities $ 548,002 $ 333,835 [1]
Maximum    
Schedule of Available-for-sale Securities [Line Items]    
Short term marketable securities maturity period 1 year 1 year
Long term marketable securities maturity period 5 years 5 years
Minimum    
Schedule of Available-for-sale Securities [Line Items]    
Long term marketable securities maturity period 1 year 1 year
Level 1:    
Schedule of Available-for-sale Securities [Line Items]    
Cash $ 451,294 $ 463,248
Cash, Aggregate Fair Value 451,294 463,248
Level 2:    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 1,232,100 1,177,891
Gross Unrealized Gains 61 159
Gross Unrealized Losses (9,608) (15,926)
Aggregate Fair Value 1,222,553 1,162,124
Cash and Cash Equivalents 334,120 261,283
Short-term Marketable Securities 340,431 567,006
Long-term Marketable Securities 548,002 333,835
Level 2: | Money market instruments    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 291,425 248,933
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Aggregate Fair Value 291,425 248,933
Cash and Cash Equivalents 291,425 248,933
Short-term Marketable Securities 0 0
Long-term Marketable Securities 0 0
Level 2: | Corporate debt securities    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 563,598 504,984
Gross Unrealized Gains 31 34
Gross Unrealized Losses (6,135) (11,541)
Aggregate Fair Value 557,494 493,477
Cash and Cash Equivalents 731 1,881
Short-term Marketable Securities 217,306 299,153
Long-term Marketable Securities 339,457 192,443
Level 2: | U.S. government agency securities    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 281,045 312,720
Gross Unrealized Gains 4 45
Gross Unrealized Losses (3,023) (3,771)
Aggregate Fair Value 278,026 308,994
Cash and Cash Equivalents 29,981 0
Short-term Marketable Securities 112,714 229,846
Long-term Marketable Securities 135,331 79,148
Level 2: | Commercial paper    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 21,864 48,103
Gross Unrealized Gains 0 11
Gross Unrealized Losses (4) (22)
Aggregate Fair Value 21,860 48,092
Cash and Cash Equivalents 11,983 10,469
Short-term Marketable Securities 9,877 37,623
Long-term Marketable Securities 0 0
Level 2: | Asset-backed securities    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 74,168 63,151
Gross Unrealized Gains 26 69
Gross Unrealized Losses (446) (592)
Aggregate Fair Value 73,748 62,628
Cash and Cash Equivalents 0 0
Short-term Marketable Securities 534 384
Long-term Marketable Securities $ 73,214 $ 62,244
[1] (1)December 31, 2022 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 27, 2023.